Skip to main content
. 2020 May 20;20:450. doi: 10.1186/s12885-020-06951-w

Table 1.

Presentation and outcomes in patients diagnosed between 2010 and 2018 with IDH-mut astrocytomas (N = 50), presented in relation to the T2-FLAIR mismatch sign presence or absence

Mismatch (N = 12, 24.0%) No mismatch (N = 38, 76.0%) P-value
Age, years, mean (SD) 35.7 (12.6) 41.9 (14.4) 0.06
Female, n (%) 7 (58.3) 16 (42.1) 0.51
Main lobe involved, n (%)
 Frontal 7 (58.3) 17 (44.7) 0.51
 Temporal 3 (25.0) 13 (34.2) 0.73
 Parietal 2 (16.7) 7 (18.4) 1.00
 Insula 0 (0.0) 1 (2.6) 1.00
Image findings, n (%)
 Right side 6 (50.0) 15 (39.5) 0.74
 Left side 6 (50.0) 23 (60.5) 0.74
 Bilateral/midline 0 (0.0) 5 (13.2) 0.32
 Conspicuous border 9 (75.0) 12 (31.6) 0.02
 Eloquence 8 (66.7) 30 (78.9) 0.45
Symptom at diagnosisa, n (%)
 Asymptomatic 0 (0.0) 3 (7.9) 1.00
 Seizure 9 (75.0) 28 (73.7) 1.00
 ICP related 3 (25.0) 11 (28.9) 1.00
 Deficit(s) 0 (0.0) 5 (13.2) 0.32
 Language deficit 2 (16.7) 2 (5.3) 0.24
 Visual deficit 2 (16.7) 4 (10.5) 0.62
 Cognitive changes 3 (25.0) 8 (21.1) 1.00
 Other symptoms 1 (8.3) 10 (26.3) 0.25
Type of surgery, n (%)
 Resection 11 (91.7) 37 (97.4) 0.43
Volumetric measurements
 Preoperative volume, ml, median (Q1-Q3) 47.4 (29.71–113.61) N = 11 63.3 (26.52–115.32) N = 37 0.91
 Postoperative volume, ml, median (Q1-Q3) 5.9 (1.67–14.81) N = 11 5.0 (0.34–16.42) N = 37 0.99
 Extent of resection, median % (Q1-Q3) 87.9 (73.60–96.63) N = 11 89.2 (48.50–99.75) N = 37 0.91
WHO grade, n (%)
 WHO grade II 5 (41.7) 24 (63.2) 0.31
 WHO grade III 6 (50.0) 13 (34.2) 0.50
 WHO grade IV 1 (8.3) 1 (2.6) 0.43

aMore than one symptom at presentation possible. Other symptoms included paresthesia, vertigo, dysphagia, among others